The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.80
Bid: 33.00
Ask: 34.60
Change: -0.20 (-0.59%)
Spread: 1.60 (4.848%)
Open: 34.00
High: 34.00
Low: 33.80
Prev. Close: 34.00
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant and variation of Options

27 Mar 2024 07:00

RNS Number : 4148I
Mercia Asset Management PLC
27 March 2024
 

RNS

27 March 2024

 

Mercia Asset Management PLC

 

("Mercia", the "Company" or the "Group")

 

Grant and variation of Options

 

Mercia Asset Management PLC (AIM: MERC), the proactive, regionally focused specialist asset manager with c.£1.5billion of assets under management, announces that options (the "CSOP Options") over a total of 1,000,000 new Ordinary shares ("Ordinary Shares") were awarded to Jocelyne Bath, the new Chief Operating Officer of the Group and a person discharging managerial responsibilities ("PDMR") pursuant to the 2014 Mercia Company Share Option Plan ("2014 CSOP"), at an exercise price of 33.00p per Ordinary Share (being the closing mid-market price of an Ordinary Share on 26 March 2024). The Options will, subject to the satisfaction of the performance condition, vest in three equal tranches on the third, fourth and fifth anniversary of the date of grant of the Options.

 

The Company further announces that, pursuant to the existing 2021 Performance Share Plan, the performance period for the existing 8,800,000 nominal cost options (the "PSP Options") over Ordinary Shares granted on 9 July 2021 to the Executive Directors and one further PDMR, has been extended.

 

Pursuant to the rules of the Mercia CSOP, the Company's Remuneration Committee has elected to vary the vesting period in which the performance condition of the PSP Options has to be satisfied, by an additional year. The Remuneration Committee considers that this is the most appropriate way of continuing to align the interests of the Executive Directors and one further PDMR with the shareholders of the Company, whilst continuing to provide a strong incentive. This facilitates the retention of high calibre individuals, who are leading the delivery of positive investment returns for Mercia's clients and as a direct consequence, the continuing successful growth of Mercia's Assets under Management and its profitability.

The PSP Options will, subject to the satisfaction of the performance condition, now vest on 9 July 2025, being the fourth anniversary of the date of grant of the options (the "Vesting Date") and will continue to be subject to a subsequent two-year holding period. The number of PSP Options which will vest on the Vesting Date will depend on the Company's total shareholder return ("TSR") over a performance period of four financial years, which started on 1 April 2021. The number of PSP Options vesting will be calculated as follows: 50% of the PSP Options will vest based on the achievement of 10.0% TSR per annum (compounded) over the new four-year performance period. Vesting will then increase on a straight-line basis to full vesting for the achievement of 20.0% TSR per annum (compounded). 

 

Following the grant of the CSOP Options and the amendment to the PSP Options above, the Company has a total of 35,039,150 options in issue pursuant to the 2014 CSOP, equating to 8.6% of the existing issued share capital of the Company.

 

Following the grant of the CSOP Options and the amendment to the PSP Options above, the PDMRs listed below hold the following options and Ordinary Shares:

 

PDMR

Role

Grant of CSOP Options or amendment of PSP Options under 2014 CSOP

Total number of options over Ordinary Shares

Interest in existing issued Ordinary Shares

Mark Payton*

Chief Executive Officer

2,596,430

5,422,932

7,184,876

Martin Glanfield**

Chief Financial Officer

2,113,652

4,536,697

1,744,947

Julian Viggars***

Chief Investment Officer

2,113,652

4,536,697

978,640

Peter Dines

Chief Operating Officer

1,976,266

4,245,813

1,078,389

Jocelyne Bath

Chief Operating Officer

1,000,000

1,000,000

-

* Including 12,793 Ordinary shares held by Katharine Yeo

** Including 125,784 Ordinary shares held by Bryonie Glanfield

*** Including 84,064 Ordinary shares held by Emma Viggars

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities:

 

1

Details of the persons discharging managerial responsibilities/person closely associated

a)

Name

(i) Mark Payton, Chief Executive Officer

(ii) Martin Glanfield, Chief Financial Officer

(iii) Julian Viggars, Chief Investment Officer

(iv) Peter Dines, Chief Operating Officer

(v) Jocelyne Bath, Chief Operating Officer

2

Reason for the notification

a)

Position/status

Executive Directors and PDMRs of the Company

b)

Initial Notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mercia Asset Management PLC

b)

Legal Entity Identifier

213800A1Q4CF57NECG66

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.00001 each

 

ISIN - GB00BSL71W47

b)

Nature of transaction

(i) to (iv): variation of performance condition of existing options.

(v): grant of options

c)

Currency

GBP

d)

Price(s) and volume(s)

Exercise Price

No. of Ordinary Shares

£0.00001

(i) 2,596,430

£0.00001

(ii) 2,113,652

£0.00001

(iii) 2,113,652

£0.00001

(iv) 1,976,266

£0.3300

(v) 1,000,000

e)

Aggregate information

- Aggregate volume

- Price

- Aggregate total

N/A - single transactions

f)

Date of the transaction

26 March 2024

g)

Place of the transaction

Outside a trading venue

 

- Ends -

 

For further information, please contact:

 

Mercia Asset Management PLC

Mark Payton, Chief Executive Officer

Martin Glanfield, Chief Financial Officer

www.mercia.co.uk

 

+44 (0)330 223 1430

 

Canaccord Genuity Limited (NOMAD and Joint Broker)

+44 (0)20 7523 8000

Simon Bridges, Emma Gabriel

Singer Capital Markets (Joint Broker)

+44 (0)20 7496 3000

Harry Gooden, James Moat

FTI Consulting

 +44 (0)20 3727 1051

Tom Blackwell, Jenny Boyd

mercia@fticonsulting.com

 

About Mercia Asset Management PLC

Mercia is a proactive, specialist asset manager focused on supporting regional SMEs to achieve their growth aspirations. Mercia provides capital across its four asset classes of venture, private equity, debt and proprietary capital: the Group's 'Complete Connected Capital'. The Group initially nurtures businesses via its third-party funds under management, then over time Mercia can provide further funding to the most promising companies, by deploying direct investment follow-on capital from its own balance sheet.

 

The Group has a strong UK footprint through its regional offices, university partnerships and extensive personal networks, providing it with access to high-quality deal flow.

 

Mercia Asset Management PLC is quoted on AIM with the EPIC "MERC".

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHJFMLTMTJTBMI
Date   Source Headline
10th Mar 20227:06 amRNSMercia’s Northern VCTs raise £40.0million
28th Feb 20227:00 amRNSFurther direct investment into MIP Diagnostics
18th Feb 20229:49 amRNSTR-1: Notification of major holdings
5th Jan 202212:36 pmRNSDirector/PDMR Dealings
5th Jan 20227:00 amRNSCompletion of the sale of Faradion
31st Dec 20217:00 amRNSSale of Faradion Limited
22nd Dec 20217:00 amRNSFurther direct investment into Intechnica Group
7th Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSSoccer Manager secures significant new licences
25th Nov 20217:00 amRNSNVT performance fee entitlement and trading update
22nd Nov 20217:00 amRNSInvestor Presentation
2nd Nov 20217:00 amRNSMercia announces a new direct investment
27th Oct 20217:00 amRNSNotice of Interim Results
26th Oct 20217:00 amRNSMercia announces new direct investment
21st Oct 20217:00 amRNSPublication of newsletter
14th Sep 202110:21 amRNSResult of AGM
14th Sep 20217:00 amRNSAGM Statement
3rd Sep 20217:00 amRNSInvestment into Locate Bio
10th Aug 20217:00 amRNSMercia accredited to deliver Recovery Loan Scheme
4th Aug 20217:00 amRNSnDreams appoints new Non-executive Chair
30th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
15th Jul 20217:00 amRNSNotification of Major Holdings
12th Jul 20217:00 amRNSGrant of Options
8th Jul 20212:56 pmRNSDirector/PDMR Dealings
6th Jul 20217:00 amRNSPreliminary results
24th Jun 20217:00 amRNSInvestor Presentation
23rd Jun 20213:16 pmRNSPerformance fee entitlement and trading update
10th May 20217:00 amRNSPublication of "The Insight" Newsletter
15th Apr 20217:00 amRNSNotice of Results
12th Apr 20217:00 amRNSVirtual shareholder event
6th Apr 20212:37 pmRNSMyHealthChecked plc signs major contract
5th Mar 202112:46 pmRNSNotification of Major Holdings
4th Mar 20214:09 pmRNSDirector/PDMR Dealings
3rd Mar 20217:00 amEQSEdison Investment Research Limited: Mercia Asset Management (MERC): The UK's top regional investor
1st Mar 20213:31 pmRNSTrading Update
1st Mar 20213:27 pmRNSSale of Oxford Genetics Limited
23rd Feb 20217:00 amRNSSoccer Manager receives £3.0million investment
2nd Feb 20217:00 amRNSSoftware and eCommerce portfolio update
29th Jan 20217:00 amRNSChange of Auditor
8th Dec 20207:00 amRNSQuarterly newsletter
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.